| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |